Former Tokai Pharmaceuticals CEO Co-Founds Startup Focused on Alzheimer's
Published: Apr 05, 2013
The former CEO of cancer drug company Tokai Pharmaceuticals, Inc. in Cambridge, Mass., Martin Williams, told Mass High Tech he will be working to build a new company he co-founded aimed at neurodegenerative and Alzheimer’s disease. Tokai announced last week that Williams had stepped down from his role as CEO but declined to say where he went when asked by Mass High Tech. Williams had taken over as CEO in September 2011, replacing acting CEO Seth Harrison. Williams was formerly chief business officer at Dicerna Pharmaceuticals Inc. and Synta Pharmaceuticals Inc. This week, Williams contacted Mass High Tech to say he is working with Yuma Therapeutics Corp., which he said ?is working on disease-modifying novel small molecules targeting the Tau pathway for Alzheimer?s disease and other neurodegenerative diseases.?